Submissions from 2024
Oncology Social Work Competencies, Opportunities, Roles, and Expertise (CORE): Results from a Role Delineation Study, Bradley Zebrack, Meredith Doherty, Michael Grignon, Ting Guan, Nina Miller, Krista Nelson, Shirley Otis-Green, Makeeta Rayton, Tara Schapmire, and Lori Wiener
Valvular Heart Disease in the Cardiac Intensive Care Unit., Emily K Zern, Rachel C Frank, and Evin Yucel
Oncologic outcomes following transanal total mesorectal excision: the United States experience., Makda Getachew Zewde, Daniel K Peyser, Allen T Yu, Antoinette Bonaccorso, Erin Moshier, Karim Alavi, Robert Goldstone, John H Marks, Justin A Maykel, Elisabeth C McLemore, Dana Sands, Scott R Steele, Steven D Wexner, Mark Whiteford, and Patricia Sylla
A foundation model for joint segmentation, detection and recognition of biomedical objects across nine modalities., Theodore Zhao, Yu Gu, Jianwei Yang, Naoto Usuyama, Ho Hin Lee, Sid Kiblawi, Tristan Naumann, Jianfeng Gao, Angela Crabtree, Jacob Abel, C Moung-Wen, Brian D. Piening, Carlo Bifulco, Mu Wei, Hoifung Poon, and Sheng Wang
Landscape of tumoral ecosystem for enhanced anti-PD-1 immunotherapy by gut Akkermansia muciniphila., Zhuxian Zhu, Jianguo Huang, Yanling Zhang, Weiwei Hou, Fei Chen, Yin-Yuan Mo, and Ziqiang Zhang
Submissions from 2023
Deep Learning Applications Using H&E Images Improve Clinical Sequencing Workflows, J Abel, Brian Piening, Carlo Bifulco, and See full list of authors in comments
Best Practices in Cardiogenic Shock, Jacob Abraham
Remote Monitoring in Heart Failure, Jacob Abraham
Case report: ex vivo tumor organoid drug testing identifies therapeutic options for stage IV ovarian carcinoma, Marwah Al-Aloosi, Amanda M Prechtl, Payel Chatterjee, Brady Bernard, Christopher J Kemp, Rachele Rosati, Robert L Diaz, Lauren R Appleyard, Shalini Pereira, Alex Rajewski, Amber McDonald, Eva J Gordon, and Carla Grandori
Gut microbiota analyses of inflammatory bowel diseases from a representative Saudi population., Raed M Alsulaiman, Abdulaziz A Al-Quorain, Fahad A Al-Muhanna, Stanley Piotrowski, Ezzeddin A Kurdi, Chittibabu Vatte, Ahmed A Alquorain, Noorah H Alfaraj, Abdulaziz M Alrezuk, Fred L Robinson, Alexa K Dowdell, Turki A Alamri, Lauren Hamilton, Hetal Lad, Hui Gao, Divya Gandla, Brendan J Keating, Ryan Meng, Brian D. Piening, and Amein K Al-Ali
Oral microbiota analyses of paediatric Saudi population reveals signatures of dental caries., Yousef M Alyousef, Stanley Piotrowski, Faisal A Alonaizan, Ahmed Alsulaiman, Ali A Alali, Naif N Almasood, Chittibabu Vatte, Lauren Hamilton, Divya Gandla, Hetal Lad, Fred L Robinson, Cyril Cyrus, Ryan Meng, Alexa K Dowdell, Brian D. Piening, Brendan J Keating, and Amein K Al-Ali
Home-Based Care Workbook, NP Amin, S Gandhi, Tyler J Gluckman, CJ Beavers, LP Cerbin, S Reddy Pitta, and BN Tehrani
Catalyzing alignment and systems transformation through cross-sector partnerships: Findings from the California Accountable Communities for Health Initiative., Lisa Angus, Alaina Dall, and Ritu Ghosal
Motor Potentials Evoked from Globus Pallidus Interna Leads Indicate Capsular Proximity During Asleep Deep Brain Stimulation for Parkinson's Disease, H Anwar, Alyx Lesko, and See all authors in comments
Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)., Paolo A Ascierto, Sanjiv S Agarwala, Allison Betof Warner, Marc S Ernstoff, Bernard A Fox, Thomas F Gajewski, Jérôme Galon, Claus Garbe, Brian R Gastman, Jeffrey E Gershenwald, Pawel Kalinski, Michelle Krogsgaard, Rom S Leidner, Roger S Lo, Alexander M Menzies, Olivier Michielin, Poulikos I Poulikakos, Jeffrey S Weber, Corrado Caracò, Iman Osman, Igor Puzanov, and Magdalena Thurin
The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022., Paolo A Ascierto, Renier Brentjens, Samir N Khleif, Kunle Odunsi, Katayoun Rezvani, Marco Ruella, Ryan J Sullivan, Bernard A Fox, and Igor Puzanov
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial., Paolo Antonio Ascierto, Evan J Lipson, Reinhard Dummer, James Larkin, Georgina V Long, Rachel E Sanborn, Vanna Chiarion-Sileni, Brigitte Dréno, Stéphane Dalle, Dirk Schadendorf, Margaret K Callahan, Marta Nyakas, Victoria Atkinson, Carlos Alberto Gomez-Roca, Naoya Yamazaki, Hussein A Tawbi, Naomey Sarkis, Deepti Warad, Sonia Dolfi, Priyam Mitra, Satyendra Suryawanshi, and Jean-Jacques Grob
Sociodemographic determinants of oral anticoagulant prescription in patients with atrial fibrillations: findings from the PINNACLE registry using machine learning., Zahra Azizi, Andrew T Ward, Donghyun J Lee, Sanchit S Gad, Kanchan Bhasin, Robert J Beetel, Tiago Ferreira, Sushant Shankar, John S Rumsfeld, Robert A Harrington, Salim S Virani, Tyler J Gluckman, Rajesh Dash, and Fatima Rodriguez
A phase 1 study of AGEN2373, a novel CD137 agonist antibody designed to avoid hepatoxicity, in patients with advanced solid tumors, MA Barve, MH Taylor, and See all authors in comments
Does Atrial Fibrillation (Afib) Impact The Rate Of 90 Days Modified Rankin Scale (mRS) In Patients Who Received Intravenous Thrombolytic (IVT) Before Endovascular Treatment (EVT)? Results From A Large Health System In Six Western States Of The US, R Bavarsad Shahripour, Alyx Lesko, and See all authors in comments
Does History Of Atrial Fibrillation (Afib) Impact TICI Scores In Acute Ischemic Stroke Patients Receiving Endovascular Treatment With Or Without IV Thrombolytics? Results From A Large Health System In Six Western States Of The United States, R Bavarsad Shahripour, Alyx Lesko, and See all authors in comments
The Impact Of Atrial Fibrillation (Afib) On The Discharge Disposition In Patients Who Received Acute Stroke Intervention Therapies. Results from A Large Health System In Six Western States Of The United States, R Bavarsad Shahripour, Alyx Lesko, and See all authors in comments
Retrospective Safety Study of Low Intensity Monitoring In Cases of Acute Ischemic Stroke That Received Thrombolytic Therapy, Y Bello, Alyx Lesko, and See all authors in comments
Cancer Immunotherapy 102, RB Bell
Enhancing Anti-tumor Immunity for the Treatment of Head and Neck Cancer, RB Bell
Enhancing Anti-tumor Immunity for the Treatment of Head and Neck Cancer, RB Bell
State of the Art of Head and Neck Cancer Immunotherapy Translational Research, RB Bell
Development and optimization of a broad hyperplex immunofluorescence assay for tumor immune microenvironment characterization, R Ben-Shimol, Carlo Bifulco, Brian Piening, and See full list of authors in comments
The International Society for Heart and Lung Transplantation/Heart Failure Society of America Guideline on Acute Mechanical Circulatory Support., Alexander M Bernhardt, Hannah Copeland, Anita Deswal, Jason Gluck, Michael M Givertz, Task Force 1; Task Force 2; Task Force 3; Task Force 4, and M Christy Smith
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1., B Besse, E Felip, R Garcia Campelo, M Cobo, C Mascaux, A Madroszyk, F Cappuzzo, W Hilgers, G Romano, F Denis, S Viteri, D Debieuvre, D Galetta, E Baldini, M Razaq, G Robinet, M Maio, A Delmonte, B Roch, P Masson, W Schuette, A Zer, J Remon, D Costantini, B Vasseur, R Dziadziuszko, G Giaccone, ATALANTE-1 study group, and Rachel E Sanborn (ATALANTE-1 study group)
A Rare Case of Demodicosis Following Treatment With Oral Fluconazole., Joshua A Bezecny, Emily Bolton, Matthew H Taylor, and Elizabeth G Berry
Translating Pressure Into Practice: Operational Characteristics of Ambulatory Hemodynamic Monitoring Program in the United States., Arvind Bhimaraj, Terrie-Ann Benjamin, Maya Guglin, Elizabeth Volz, Hirak Shah, Ashrith Guha, Kunjan Bhatt, Mosi Bennett, Andrew Sauer, Marat Fudim, Monique Robinson, Evan D Muse, Thomas J Heywood, Orvar Jonsson, and Jacob Abraham
Translating Pressure Into Practice: Operational Characteristics of Ambulatory Hemodynamic Monitoring Program in the United States., Arvind Bhimaraj, Terrie-Ann Benjamin, Maya Guglin, Elizabeth Volz, Hirak Shah, Ashrith Guha, Kunjan Bhatt, Mosi Bennett, Andrew Sauer, Marat Fudim, Monique Robinson, Evan D Muse, Thomas J Heywood, Orvar Jonsson, and Jacob Abraham
Biomarker Testing, C Bifulco
Empowering Precision Medicine With Genomics, Multi-Modal AI And Real-World Data, C Bifulco
Spatial Biology: Driving Clinical Trials and Diagnostics in a Multiomics AI-Powered Era, C Bifulco
Spatial Omics: an Evolutionary Prospective, C Bifulco
The overview of Spatial Technologies in the use of Immunopathology, C Bifulco
Transforming Patient Care Through Data and AI, C Bifulco
Spatial Biology as a Tool to reveal Mechanisms of Immune Exclusion, Carlo Bifulco
Spatial Biology in a Multiomics AI-Powered Era, Carlo Bifulco
Spatial Omics in Immunotherapy Trials: Unpacking the Challenges, Carlo Bifulco
Implementing CGP plus HRD testing In-house in a Large US Healthcare System, Carlo Bifulco and Brian Piening
Difficult Conversations: Outcomes of Emergency Department Nurse-Directed Goals-of-Care Discussions., Suzanne Bigelow, Ron Medzon, Mari Siegel, and Ruyun Jin
Severe Hemolytic Disease of the Newborn due to Anti-Di, Douglas Blackall
A phase 1, open-label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of PF-07799933 (ARRY-440) as a single agent and in combination therapy in participants 16 years and older with advanced solid tumors with BRAF alterations, JTT Black, MH Taylor, and See all authors in comments
Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) in patients with recurrent platinum refractory/resistant ovarian cancer (041), Bruno Bockorny, Steven O'Day, Kim Margolin, Rachel E Sanborn, Timothy S Kristedja, and See all authors in comments
If the Fates Allow: The Zero-Sum Game of ISCHEMIA-EXTEND., Steven M Bradley and Tyler J Gluckman
Improving patient outcomes through an evidence-based practice nursing boot camp, Kevin Brandini
Improving patient outcomes through an evidence-based practice nursing boot camp (program evaluation), Kevin Brandini
Results from an expanded phase 1 trial of botensilimab, a multifunctional anti-CTLA-4, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer, AJ Bullock, RE Sanborn, and See all authors in comments
MINI INTENSIVE: APP: Creating a Sustainable and Achievable Culture Independence Salons F-H, Denise K. Busman, Tyler J Gluckman, and See full list of authors in comments
Temsirolimus (T) in patients (pts) with solid tumors with PIK3CA mutation (mut): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study, CJ Calfa, WJ Urba, and See all authors in comments
Minimal residual disease by circulating tumor DNA as a biomarker of recurrence free survival in resected high-risk melanoma patients treated with mRNA-4157/V940, a personalized cancer vaccine, and pembrolizumab, Matteo S. Carlino, Matthew H. Taylor, and See all authors in comments
CT275 / 15 - Phase 1 clinical update of allogeneic invariant natural killer T cells (iNKTs), agenT-797, alone or in combination with pembrolizumab or nivolumab in patients with advanced solid tumors, B Carneiro, Rachel E Sanborn, and See full list of authors in comments
Advance Care Planning and End-of-Life Education in Heart Failure: Insights From the NCDR PINNACLE Registry., Casey E Cavanagh, Lindsey Rosman, Philip Chui, Karl Minges, Nihar R Desai, Sarah Goodlin, Savitri Fedson, John A Spertus, Tyler J Gluckman, Yang Song, Luke Zheng, Alexander Turchin, Gheorghe Doros, Jane J Lee, and Matthew M Burg
Direct Oral Anticoagulants and Warfarin Safety in Rural Patients with Obesity., Zachary R Caverley, Ross J Bindler, Pamela Soh, and Sherri Mendelson
Spontaneous coronary artery dissection: An underrecognized cause of ACS., Zachary R Caverley and Lori Tam
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial., Eric X Chen, Jonathan M Loree, Emma Titmuss, Derek J Jonker, Hagen F Kennecke, Scott Berry, Felix Couture, Chaudharry E Ahmad, John R Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Alice C Wei, Dongsheng Tu, and Chris J O'Callaghan
HB-300, a novel arenavirus-based cancer immunotherapy in patients with metastatic castration-resistant prostate cancer, D Chism, Brendan Curti, and See all authors in comments
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial., Byoung Chul Cho, Dong-Wan Kim, Alexander I Spira, Jorge E Gomez, Eric B Haura, Sang-We Kim, Rachel E Sanborn, Eun Kyung Cho, Ki Hyeong Lee, Anna Minchom, Jong-Seok Lee, Ji-Youn Han, Misako Nagasaka, Joshua K Sabari, Sai-Hong Ignatius Ou, Patricia Lorenzini, Joshua M Bauml, Joshua C Curtin, Amy Roshak, Grace Gao, John Xie, Meena Thayu, Roland E Knoblauch, and Keunchil Park
Sexual and Gender Diversity in Pediatric Neurology: Why We Care., Alison Christy, Jaclyn Martindale, Jennifer Hranilovich, Casey Orozco-Poore, Finley Kernan-Schloss, Chase T M Anderson, Jonathan Strober, Wendy Mitchell, and Mackenzie P Lerario
Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments., Michael D Chuong, Mary Ann Clark, Lauren E Henke, Amar U Kishan, Lorraine Portelance, Parag J Parikh, Michael F Bassetti, Himanshu Nagar, Stephen A Rosenberg, Minesh P Mehta, Tamer Refaat, Justin M Rineer, Adam Smith, Steven Seung, Bassem I Zaki, Martin Fuss, and Raymond H Mak
Associations between feeding and development in preterm infants in the NICU and throughout the first year of life., Ashleigh Connell, Kati Knudsen, Horia Marginean, and Michele Raddish
Abstract CT123: Trial in progress: First-in-human immunotherapy-trio for advanced head and neck squamous cell carcinoma, MA Couey, Matthew H Taylor, William L. Redmond, Brady Bernard, Richard Bryan Bell, Carlo Bifulco, Brian D. Piening, Walter Urba, Bernard A Fox, and Rom Leidner
Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas., Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Thomas F Gajewski, Martin Gutierrez, Hun Ju Lee, Ajay K Gopal, Paolo Caimi, Elisabeth I Heath, John A Thompson, Sahar Ansari, Celine Jacquemont, Ariel Topletz-Erickson, Peigen Zhou, Michael W Schmitt, and Juneko E Grilley-Olson
Interdisciplinary Involvement in HTN Management, Kirsten Curcio, Maurice N. Tran, and Estera Ianciuc
Order Set Usage is Associated With Lower Hospital Mortality in Patients With Sepsis., chris dale, Shelley Schoepflin Sanders, Shu-Ching Chang, Omar Pandhair, Naomi G Diggs, Whitney Woodruff, David N Selander, Nicholas M Mark, Sarah Nurse, Mark David Sullivan, Liga Mezaraups, and D Shane O'Mahony
Piperacillin-Tazobactam Compared With Cefoxitin as Antimicrobial Prophylaxis for Pancreatoduodenectomy: A Randomized Clinical Trial., Michael I D'Angelica, Ryan J Ellis, Jason B Liu, Brian C Brajcich, Mithat Gönen, Vanessa M Thompson, Mark E Cohen, Susan K Seo, Emily C Zabor, Michele L Babicky, David J Bentrem, Stephen W Behrman, Kimberly A Bertens, Scott A Celinski, Carlos H F Chan, Mary Dillhoff, Matthew E B Dixon, Carlos Fernandez-Del Castillo, Sepideh Gholami, Michael G House, Paul J Karanicolas, Harish Lavu, Shishir K Maithel, John C McAuliffe, Mark J Ott, Bradley N Reames, Dominic E Sanford, Umut Sarpel, Courtney L Scaife, Pablo E Serrano, Travis Smith, Rebecca A Snyder, Mark S Talamonti, Sharon M Weber, Adam C Yopp, Henry A Pitt, and Clifford Y Ko
Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas., Andrea R Daniel, Chang Su, Nerissa T Williams, Zhiguo Li, Jianguo Huang, Omar Lopez, Lixia Luo, Yan Ma, Lorraine da Silva Campos, Sara R Selitsky, Jennifer L Modliszewski, Siyao Liu, Rosa Hernansaiz-Ballesteros, Yvonne M Mowery, Diana M Cardona, Chang-Lung Lee, and David G Kirsch
Assessing Competencies and Giving Feedback, CH Davies
What About Other Non-Invasive (Non-Pharmacologic) Therapies for Refractory Angina?, CH Davies
Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care., Jaydira Del Rivero, Josh Mailman, Michael W Rabow, Jennifer A Chan, Sarah Creed, Hagen F Kennecke, Janice Pasieka, Jennifer Zuar, Simron Singh, and Lauren Fishbein
Frailty is Not Associated with Worse Outcomes following Lower Extremity Angiograms for Limb Ischemia in Nonagenarians., Jaclyn DeRieux, Dina Obed, Arianne Johnson, Michael Paisley, Michelle Wang, and Kevin M Casey
Longitudinal Policy and Systems Change as a Component of Community Power., Claire Devine, Ritu Ghosal, Maggie Weller, Taylor Doren, Chia Hua Yu, Roxanne Marsillo, and Natalie Royal Kenton
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results., Adi Diab, Helen Gogas, Shahneen Sandhu, Georgina V Long, Paolo A Ascierto, James Larkin, Mario Sznol, Fabio Franke, Tudor E Ciuleanu, Caio Pereira, Eva Muñoz Couselo, Fernanda Bronzon Damian, Michael Schenker, Aldo Perfetti, Celeste Lebbe, Gaëlle Quéreux, Friedegund Meier, Brendan Curti, Carlos Rojas, Yull Arriaga, Haisu Yang, Ming Zhou, Shruthi Ravimohan, Paul Statkevich, Mary A Tagliaferri, and Nikhil I Khushalani
Participation in genetic screening: testing different outreach methods across a diverse hospital system based patient population., Lindsay Dickey, Benjamin Gronowski, Kyle Jones, J B Rinaldi, Kate Emery, Jon Clemens, Ora K Gordon, and Keri B Vartanian
Immunotherapy for brain metastases and primary brain tumors., Anna M Di Giacomo, Maximilian J Mair, Michele Ceccarelli, Andrea Anichini, Ramy Ibrahim, Michael Weller, Michael Lahn, Alexander M M Eggermont, Bernard Fox, and Michele Maio
ASHP Foundation Pharmacy Forecast 2023: Strategic Planning Guidance for Pharmacy Departments in Hospitals and Health Systems., Joseph T DiPiro, Todd W Nesbit, Charles Reuland, Francesca E Cunningham, Pamela Schweitzer, Marie A Chisholm-Burns, Leyner Martinez, Rita Shane, Christopher M Scott, Scott D Nelson, Dara L E Mize, Elva Van Devender, and Lance Oyen
MDR1-EXPRESSING CD4, Anthony Di Roio, Margaux Hubert, Laurie Besson, Marion Bossennec, Céline Rodriguez, Yenkel Grinberg-Bleyer, Guilhem Lalle, Lyvia Moudombi, Raphael Schneider, Cyril Degletagne, Isabelle Treilleux, Daniel J Campbell, Séverine Metzger, Thomas Duhen, Olivier Trédan, Christophe Caux, and Christine Ménétrier-Caux
Exploring the frequency of hospital-based chaplain and nursing interactions, Sheila Doucette
Co-Designing an Initiative to Increase Shared Access to Older Adults' Patient Portals: Stakeholder Engagement., Vadim Dukhanin, Jennifer L Wolff, Liz Salmi, Kendall Harcourt, Deborah Wachenheim, Ira Byock, Matthew J Gonzales, Doug Niehus, Marianne Parshley, Caroline Reay, Sara Epstein, Supriya Mohile, Timothy W Farrell, Mark A Supiano, Anushka Jajodia, Catherine M DesRoches, and Shared Access Project Team
Functional Outcomes in Patients with Large Vessel Occlusion Anterior Circulation Strokes Presenting with Low NIHSS Score with or without Thrombectomy Treatment, M Duncan, Alyx Lesko, and See all authors in comments
Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study., Herbert L Duvivier, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Tareq Al Baghdadi, Ajjai S Alva, Stephanie A Dublis, Timothy L Cannon, Carmen J Calfa, Rui Li, Deepti Behl, Vi K Chiu, Philip J Gold, Alissa S Marr, Kathryn F Mileham, Steven Francis Powell, Jordi Rodon, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, and Richard L Schilsky
Registry Data Show Complication Rates and Cost in Revision Hip Arthroplasty., Paul J Duwelius, Richard D Southgate, James P Crutcher, Genevieve M Rollier, Hsin-Fang Li, Katie S Sypher, and Geoffrey S Tompkins
Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC., Joseph E Ebinger, Tyler J Gluckman, Jose Magraner, Shih-Ting Chiu, Deanna Rider, Chelsey Thomas, Sandeep R Das, P Michael Ho, Satya Shreenivas, and Steven Bradley
Game-Based Learning in Neuroscience: Key Terminology, Literature Survey, and How To Guide to Create a Serious Game., Sarah L Edwards, Eric Gantwerker, Michael Cosimini, Alison L Christy, Angel W Kaur, Ann K Helms, Mikaela L Stiver, and Zachary London
Results from a phase 1a/1b study of botensilimab (BOT), a novel innate/adaptive immune activator, plus balstilimab (BAL; anti-PD-1 antibody) in metastatic heavily pretreated microsatellite stable colorectal cancer (MSS CRC)., Anthony B. El-Khoueiry, K A Margolin, Rachel E Sanborn, and See all authors in comments
Chapter: High-sensitivity C-reactive protein, DI Feldman, RS Blumenthal, and Tyler J Gluckman
NKG2A expression on tumor reactive CD8 T cells is induced by IL-12, O Fesneau, J Huang, T Duhen, and See full list of authors in comments
Immune Interception of Pre-Malignancy, B Fox
Cancer Vaccines, Bernard Fox